Dr Reddy's gets FDA nod for 'Tosymra' migraine nasal spray

The drug maker said the audit of its API manufacturing plant at Miryalaguda in Telangana, by the US FDA, has been completed.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news